Literature DB >> 25516208

Forkhead box C1 promoter upstream transcript, a novel long non-coding RNA, regulates proliferation and migration in basal-like breast cancer.

Juntao Liu1, Lei Shen2, Jie Yao3, Yi Li4, Yongcheng Wang5, Hong Chen6, Peiliang Geng4.   

Abstract

Recent studies have shown that long non‑coding RNAs (lncRNAs) have crucial regulating roles in carcinogenesis. Forkhead box C1 (FOXC1) is an important cancer‑associated gene in basal‑like breast cancer (BLBC). In the present study, a novel lncRNA, FOXC1 promoter upstream transcript (FOXCUT) was investigated in BLBC patients using polymerase chain reaction analysis. The results showed that the expression of FOXCUT and FOXC1 were positively correlated. When the expression of FOXCUT was downregulated by small interfering RNA, the expression of FOXC1 was similarly reduced. Furthermore, in MDA‑MB‑231 and MDA‑MB‑468 breast cancer cells, knockdown of FOXCUT markedly inhibited cell proliferation and migration in vitro. In conclusion, FOXCUT lncRNA may be functionally involved in the tumor progression of BLBCs through the regulation of its paired mRNA, FOXC1, demonstrating that FOXCUT may serve as a novel biomarker and therapeutic target in BLBCs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25516208     DOI: 10.3892/mmr.2014.3089

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  15 in total

1.  FOXCUT Promotes the Proliferation and Invasion by Activating FOXC1/PI3K/AKT Pathway in Colorectal Cancer.

Authors:  Xiaojie Zhang; Shanyong Yi; Guochen Xing; Huili Wu; Ying Zhu; Xiaodan Guo; Lei Zhang
Journal:  Cancer Manag Res       Date:  2020-07-24       Impact factor: 3.989

2.  Coordinated targeting of MMP-2/MMP-9 by miR-296-3p/FOXCUT exerts tumor-suppressing effects in choroidal malignant melanoma.

Authors:  Xinhe Wang; Yuedong Hu; Jianyi Cui; Yun Zhou; Lei Chen
Journal:  Mol Cell Biochem       Date:  2017-12-19       Impact factor: 3.396

Review 3.  A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.

Authors:  Sara Malih; Massoud Saidijam; Narges Malih
Journal:  Tumour Biol       Date:  2015-12-11

4.  High Expression of the Newly Found Long Noncoding RNA Z38 Promotes Cell Proliferation and Oncogenic Activity in Breast Cancer.

Authors:  Rilin Deng; Bin Liu; Yan Wang; Feng Yan; Shifan Hu; Hongcan Wang; Tingting Wang; Bin Li; Xiyun Deng; Shuanglin Xiang; Yinke Yang; Jian Zhang
Journal:  J Cancer       Date:  2016-03-18       Impact factor: 4.207

Review 5.  Long non-coding RNA implicated in the invasion and metastasis of head and neck cancer: possible function and mechanisms.

Authors:  Xiaobo Luo; Yan Qiu; Yuchen Jiang; Fangman Chen; Lu Jiang; Yu Zhou; Hongxia Dan; Xin Zeng; Yu L Lei; Qianming Chen
Journal:  Mol Cancer       Date:  2018-01-24       Impact factor: 27.401

Review 6.  FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles.

Authors:  Zhi Yang; Shuai Jiang; Yicheng Cheng; Tian Li; Wei Hu; Zhiqiang Ma; Fulin Chen; Yang Yang
Journal:  Ther Adv Med Oncol       Date:  2017-11-23       Impact factor: 8.168

Review 7.  Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis.

Authors:  Chunyang Jiang; Xin Li; Hui Zhao; Huibin Liu
Journal:  Mol Cancer       Date:  2016-09-29       Impact factor: 27.401

Review 8.  Current research on head and neck cancer-associated long noncoding RNAs.

Authors:  Wei Song; Yimin Sun; Jie Lin; Xiaoqin Bi
Journal:  Oncotarget       Date:  2017-11-22

9.  Transcriptome Signatures of Canine Mammary Gland Tumors and Its Comparison to Human Breast Cancers.

Authors:  Kang-Hoon Lee; Hyoung-Min Park; Keun-Hong Son; Tae-Jin Shin; Je-Yoel Cho
Journal:  Cancers (Basel)       Date:  2018-09-07       Impact factor: 6.639

Review 10.  The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge.

Authors:  Daiana Cosmina Temian; Laura Ancuta Pop; Alexandra Iulia Irimie; Ioana Berindan-Neagoe
Journal:  J Breast Cancer       Date:  2018-09-20       Impact factor: 3.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.